MXPA05000024A - Derivados novedosos de aril-{4- halo-4- [(heteroarilmetilamino) metil]-piperidin -1-il} metanona, metodos de produccion y uso de los mismos como medicamentos. - Google Patents

Derivados novedosos de aril-{4- halo-4- [(heteroarilmetilamino) metil]-piperidin -1-il} metanona, metodos de produccion y uso de los mismos como medicamentos.

Info

Publication number
MXPA05000024A
MXPA05000024A MXPA05000024A MXPA05000024A MXPA05000024A MX PA05000024 A MXPA05000024 A MX PA05000024A MX PA05000024 A MXPA05000024 A MX PA05000024A MX PA05000024 A MXPA05000024 A MX PA05000024A MX PA05000024 A MXPA05000024 A MX PA05000024A
Authority
MX
Mexico
Prior art keywords
methyl
methanone
piperidin
amino
fluoro
Prior art date
Application number
MXPA05000024A
Other languages
English (en)
Spanish (es)
Inventor
Francis Colpaert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MXPA05000024A publication Critical patent/MXPA05000024A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MXPA05000024A 2002-06-18 2003-06-18 Derivados novedosos de aril-{4- halo-4- [(heteroarilmetilamino) metil]-piperidin -1-il} metanona, metodos de produccion y uso de los mismos como medicamentos. MXPA05000024A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207470A FR2840900B1 (fr) 2002-06-18 2002-06-18 Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments
PCT/FR2003/001873 WO2003106449A1 (fr) 2002-06-18 2003-06-18 Nouveaux derives d'aryl-{4-halogeno-4-[heteroaryl-methylamino)-methyl]-piperidin-1-yl}-methanone, leur procede de preparation et leur utilisation a titre de medicaments

Publications (1)

Publication Number Publication Date
MXPA05000024A true MXPA05000024A (es) 2005-04-08

Family

ID=29595331

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05000024A MXPA05000024A (es) 2002-06-18 2003-06-18 Derivados novedosos de aril-{4- halo-4- [(heteroarilmetilamino) metil]-piperidin -1-il} metanona, metodos de produccion y uso de los mismos como medicamentos.

Country Status (14)

Country Link
US (1) US7547700B2 (enExample)
EP (1) EP1539738B1 (enExample)
JP (1) JP4699027B2 (enExample)
CN (1) CN1308325C (enExample)
AT (1) ATE424396T1 (enExample)
AU (1) AU2003258816B2 (enExample)
BR (1) BRPI0311976B8 (enExample)
CA (1) CA2489723C (enExample)
DE (1) DE60326468D1 (enExample)
ES (1) ES2321927T3 (enExample)
FR (1) FR2840900B1 (enExample)
MX (1) MXPA05000024A (enExample)
WO (1) WO2003106449A1 (enExample)
ZA (1) ZA200500467B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852244B1 (fr) 2003-03-13 2007-09-07 Pf Medicament Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene
FR2891274B1 (fr) * 2005-09-27 2007-11-23 Pierre Fabre Medicament Sa Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires.
CA2724737A1 (en) * 2008-05-19 2009-11-26 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
US8389534B2 (en) * 2008-05-19 2013-03-05 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
FR2946344B1 (fr) * 2009-06-05 2012-05-25 Pf Medicament Nouveaux derives d'aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl} methanone, leur procede de preparation et leur utilisation a titre de medicaments
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
US10626105B2 (en) 2016-09-22 2020-04-21 Auspex Pharmaceuticals, Inc. Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds
WO2019016357A1 (en) 2017-07-20 2019-01-24 Neurolixis USE OF SELECTIVE 5-HT1A SEROTONIN RECEPTOR AGONISTS TO TREAT THE ADVERSE EFFECTS OF VMAT INHIBITORS
WO2023144166A1 (en) 2022-01-26 2023-08-03 Neurolixis Use of serotonin 5-ht1a receptor agonists to treat diseases associated with sudden unexpected death in epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN169588B (enExample) * 1986-10-07 1991-11-16 Pfizer Hospital Prod
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
FR2784378B1 (fr) * 1998-10-09 2000-12-29 Pf Medicament Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2820743B1 (fr) * 2001-02-09 2005-02-25 Pf Medicament Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine

Also Published As

Publication number Publication date
CN1308325C (zh) 2007-04-04
ES2321927T3 (es) 2009-06-15
BRPI0311976B1 (pt) 2015-08-18
AU2003258816A1 (en) 2003-12-31
HK1075452A1 (en) 2005-12-16
ATE424396T1 (de) 2009-03-15
US20060100244A1 (en) 2006-05-11
AU2003258816B2 (en) 2008-08-21
WO2003106449A8 (fr) 2005-02-17
JP4699027B2 (ja) 2011-06-08
JP2005534668A (ja) 2005-11-17
CA2489723C (fr) 2011-08-02
DE60326468D1 (de) 2009-04-16
FR2840900B1 (fr) 2005-02-25
BR0311976A (pt) 2005-03-29
CA2489723A1 (fr) 2003-12-24
BRPI0311976B8 (pt) 2021-05-25
CN1675194A (zh) 2005-09-28
EP1539738B1 (fr) 2009-03-04
US7547700B2 (en) 2009-06-16
FR2840900A1 (fr) 2003-12-19
ZA200500467B (en) 2005-12-28
WO2003106449A1 (fr) 2003-12-24
EP1539738A1 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
EP1497266B1 (en) Quinoline derivatives and their use as 5-ht6 ligands
EP0691960B1 (en) Antipsychotic benzimidazole derivatives
JP5685082B2 (ja) オルメサルタンメドキソミルの調製または精製の方法
WO1997047601A1 (en) Fused heterocyclic compounds and medicinal uses thereof
KR900008674B1 (ko) N-(피페리디닐-알킬)-카복스아미드의 제조방법
JPH0523269B2 (enExample)
JP2007505075A (ja) キノリン化合物およびそれを含む医薬組成物
MXPA05000024A (es) Derivados novedosos de aril-{4- halo-4- [(heteroarilmetilamino) metil]-piperidin -1-il} metanona, metodos de produccion y uso de los mismos como medicamentos.
JPH02138266A (ja) ６‐フェニル‐３‐（ピペラジニルアルキル）‐２，４（１ｈ，３ｈ）‐ピリミジンジオン誘導体
FI85484B (fi) Foerfarande foer framstaellning av antipsykotiska pyridinylpiperazinderivat som innehaoller en kondenserad ring.
KR20010041341A (ko) 벤질피페라지닐 및 벤질피페리디닐 에탄온 유도체, 이의제조 방법 및 도파민 ｄ４ 수용체 길항제로서의 이의 용도
US20040034036A1 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
US5472966A (en) Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
WO1998030559A1 (en) Process for the production of tetrazolylbenzopyrans
HU184059B (en) Process for preparing new 1,2-benzothiazine-1,1-dioxyde derivatives and pharmaceutical sompositions containing such compounds
HK1075452B (en) Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl -methanone derivatives, methods for production and use thereof as medicaments
HK1074439B (en) Quinoline derivatives and their use as 5-ht6 ligands
HK1115875A (en) Quinoline derivatives and their use as 5-ht6 ligands
MXPA99005997A (en) Sulfonamide compounds having 5-ht receptor activity
KR20010072407A (ko) Ｎ-치환 아자비시클로헵탄 유도체, 그의 제조 및 용도

Legal Events

Date Code Title Description
FG Grant or registration